Brief: Psyence Biomedical Ltd. Approved To List On Nasdaq Following Completion Of Business Combination Agreement With Newcourt Acquisition Corp
25/01/2024 23:34
Psyence Group Inc PSYG.CD :
* PSYENCE BIOMEDICAL LTD. APPROVED TO LIST ON NASDAQ
FOLLOWING
COMPLETION OF BUSINESS COMBINATION AGREEMENT WITH NEWCOURT
ACQUISITION CORP
Source text for Eikon: ID:nGNX1t7DXt
Further company coverage: PSYG.CD
Recent news on Psyence
See all newsBrief: Psyence Group To Consolidate Shares 15 To 1 Effective April 23, 2025
Brief: Psyence Group Enters Into Debt-For-Equity Swap Agreement With Its Nasdaq-Listed Associate, Psyence Biomedical
Brief: Psyence Biomed Enters Into Agreement To Acquire Stake In Psylabs
Brief: Psyence Biomedical Ltd. Approved To List On Nasdaq Following Completion Of Business Combination Agreement With Newcourt Acquisition Corp
MGC Pharmaceuticals - September 2023 Quarter Activity Report